Navigation Links
ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2008 Financial Results
Date:3/25/2009

SAN DIEGO, March 25 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX) today reported financial results for the fourth quarter and year ended December 31, 2008.

"2008 was a transition year for ADVENTRX in which we advanced a new business model focused on lower-risk reformulations of previously-approved drugs. We achieved important milestones with our new lead programs, but given the difficult economic environment, we were unable to attract financing on terms that would allow us to pursue their commercialization," said Brian M. Culley, ADVENTRX's Chief Business Officer. "As a result, over the past several months, we have implemented significant cost-containment measures and, in December, publicly announced that we were exploring strategic options as a means to continue the necessary activities, whether by us or a partner, to bring our lead product candidates to market."

Three-Month Period Ended December 31, 2008 Operating Results

ADVENTRX's net loss was $7.5 million, or $0.08 per share, for the three-month period ended December 31, 2008, compared to a net loss of $5.4 million, or $0.06 per share, for the same period in 2007. Included in the net loss for the three-month period ended December 31, 2008 were non-cash, share-based compensation expenses amounting to $0.2 million, compared to $0.5 million for the same period in 2007.

Research and development, or R&D, expenses increased by $1.0 million, or 25%, to $4.8 million for the three-month period ended December 31, 2008, from $3.9 million for the same period a year ago. The increase was primarily due to a $2.3 million increase in expenses related to external research-related manufacturing and regulatory and quality assurance activities related to ANX-530 and ANX-514, a $0.4 million increase in external clinical trial expe
'/>"/>

SOURCE ADVENTRX Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. ADVENTRX Announces Further Cost-Cutting Measures
2. ADVENTRX Provides Update on Strategic Transaction Process
3. ADVENTRX Announces Further Cost-Cutting Measures
4. ADVENTRX Exploring Strategic Options
5. ADVENTRX Pharmaceuticals Reports Third Quarter 2008 Financial Results and Business Update
6. ADVENTRX Pharmaceuticals to Present at the Rodman & Renshaw 10th Annual Global Healthcare Conference
7. ADVENTRX Announces Restructuring and Cost Reduction Initiatives
8. ADVENTRX Pharmaceuticals to Report Second Quarter 2008 Results
9. ADVENTRX Settles Dispute With Former Licensee
10. ADVENTRX Pharmaceuticals to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference
11. ADVENTRX Appoints Vice President of Manufacturing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... August 28, 2014 PrimeSource Building ... materials, selected SoundConnect to support their ... based audio and web conferencing platform GlobalMeet powered ... PrimeSource’s employees’ needs. SoundConnect delivers award winning ... PrimeSource Building Products will be utilizing GlobalMeet ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 Varian Medical ... expand its current Salt Lake City manufacturing facility and ... of Utah to ultimately create 1,000 new full time ... , “Utah is home to hardworking people with ... be credited with Varian’s success in the manufacturing of ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 In ... through Lawrence Livermore National Security LLC ... develop and deliver a state-of-the-art laser system for ... (ELI Beamlines), under construction in the Czech Republic. ... the laser system, called the " High repetition-rate ...
(Date:8/27/2014)... of nature,s mysteries is how plants survive impact ... the sun,s rays, while using this energy for ... in the plant,s blades quickly dissipate the energy ... quakes. Researchers at DTU Physics have now managed ... algae and bacteria contain light-absorbing proteins which play ...
Breaking Biology Technology:PrimeSource Chooses SoundConnect as Collaboration Provider 2Varian Medical Systems Groundbreaking on Facility Expansion Triggers Influx of New Jobs to Salt Lake 2Varian Medical Systems Groundbreaking on Facility Expansion Triggers Influx of New Jobs to Salt Lake 3LLNL Synchs up with ELI Beamlines on Timing System 2LLNL Synchs up with ELI Beamlines on Timing System 3DTU researchers film protein quake for the first time 2
... Pa., Dec. 1 BioTrends Research Group, Inc. released its third ... to two ongoing studies BioTrends conducts -- TreatmentTrends(TM) : ... the results of an on-line survey completed by 200 Nephrologists from ... on the management of renal anemia and hyperphosphatemia. , ...
... (Nasdaq: ANDS ) today announced that the U.S. ... to ANA598 for the treatment of chronic hepatitis C virus ... polymerase inhibitor. Anadys is currently enrolling patients in a ... chronically infected with HCV. , , ...
... Convention is pleased to announce that Matthew Heyman joined the organization ... 1, 2008. , ... Rockville, Md. (Vocus) December 1, ... to announce that Matthew Heyman joined the organization as vice president ...
Cached Biology Technology:European Nephrologists Share Insights on the Management of Renal Anemia and Hyperphosphatemia in Latest BioTrends Report 2ANA598 Receives Fast Track Designation From the FDA for the Treatment of Chronic Hepatitis C Infection 2ANA598 Receives Fast Track Designation From the FDA for the Treatment of Chronic Hepatitis C Infection 3ANA598 Receives Fast Track Designation From the FDA for the Treatment of Chronic Hepatitis C Infection 4ANA598 Receives Fast Track Designation From the FDA for the Treatment of Chronic Hepatitis C Infection 5USP Names Matthew Heyman Vice President of External Affairs and Strategic Integration 2USP Names Matthew Heyman Vice President of External Affairs and Strategic Integration 3
(Date:8/28/2014)... groups and clinicians is critical to the development ... of Georgia research. , A qualitative study of ... that role models for successful breastfeeding help positively ... "Mothers who received that support are more likely ... Alex Anderson, an associate professor in the College ...
(Date:8/28/2014)... method for delivering compounds that could positively ... AIDS may be possible, thanks to researchers ... A semi-soft vaginal suppository made from the ... the antiviral drug Tenofovir provides a woman-initiated, ... spread of sexually transmitted infections during unprotected ...
(Date:8/28/2014)... new method for measuring and imaging how quickly blood ... better understand how drug abuse affects the brain, which ... and lead to better treatment options for recovering drug ... researchers from Stony Brook University in New York, USA ... today in The Optical Society,s (OSA) open-access journal ...
Breaking Biology News(10 mins):Breastfeeding study shows need for effective peer counseling programs 2Sensory-tested drug-delivery vehicle could limit spread of HIV, AIDS 2Sensory-tested drug-delivery vehicle could limit spread of HIV, AIDS 3This is your brain's blood vessels on drugs 2This is your brain's blood vessels on drugs 3
... 50,000 people have uncovered several DNA sequence variations associated ... The findings, reported in Nature Genetics , may ... mechanisms for abnormal heart rhythms and sudden cardiac death. ... complex," says co-author Glenn I. Fishman, MD, the William ...
... With chitlins about to make their annual appearance on ... news for millions of people who love that delicacy of ... the first identification of an ingredient in cilantro that quashes ... to drive people from the house when chitlins are cooking. ...
... news aggregator that compiles life sciences-focused news stories from an ... daily email digest format, free of charge to subscribers. In ... or tweet their favorite news stories, and even submit news ... direct to their email in-box on any the following topics: ...
Cached Biology News:DNA sequence variations linked to electrical signal conduction in the heart 2Cilantro ingredient can remove foul odor of 'chitlins' 2
...
Human sIL-2R/CD25 ELI-PAIR Kit...
STX18 Immunogen: STX18 (NP_058626, 101 a.a. ~ 200 a.a) partial recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only...
Lipid Phosphate Phosphohydrolase 2...
Biology Products: